New target for cardioprotective therapies
A novel target for cardioprotective therapies – enzyme N6-trimethyllysine dioxygenase (TMLD) – has been identified by researchers from the Latvian Institute of Organic Synthesis (LIOS),
24/11/2021
A novel target for cardioprotective therapies – enzyme N6-trimethyllysine dioxygenase (TMLD) – has been identified by researchers from the Latvian Institute of Organic Synthesis (LIOS),
Input your search keywords and press Enter.